asa glp 1 agonists GLP-1 and Anesthesia: Considerations and Cautions for CRNAs Holding GLP-1 Agonists Prior to

Tirzepatide as compared with semaglutide for the treatment of obesity in adults without diabetes

In early clinical studies, retatrutide has delivered unprecedented weight lossup to 24.2% of body weight in less than a yearwhile also improving blood pressure, cholesterol, and liver fat content

Heart failure and type 2 diabetes: From cardiovascular outcome trials, with hope

Clinical trials and regulatory bodies, including the MHRA (Medicines and Healthcare Products Regulatory Agency) and the EMA (European Medicines Agency), have approved it for managing diabetes and weight loss[1]

Bone 81:459467 Abo-Elenin MHH, Kamel R, Nofal S, Ahmed AAE (2025) The crucial role of beta-catenin in the osteoprotective effect of semaglutide in an ovariectomized rat model of osteoporosis

Mode of Action GLP-1 receptors are available in many part of the human body which allow the GLP-1 hormone to exert its functions and effects, reducing body weight, systolic blood pressure, HbA1c and lipid profile ( Figure 3 ) Figure 3: GLP-1 effect on different parts of the body